Jefferies maintained its Buy rating on Legend Biotech Corp . (NASDAQ:LEGN) but reduced the stock's price target from $94.00 to $91.00. The adjustment follows reports of Johnson & Johnson's $334 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback